Author

Maya Caroline Andre

University Children's Hospital TübingenORCID 0000-0003-1555-2011Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Ambrine SahaliD· 1 shared Amelie MuthiD· 1 shared Annette Frank· 1 shared Annika Maria Dufour· 1 shared Aylin Neyazi· 1 shared Ayline KübleriD· 1 shared B Krämer· 1 shared Ben Felix Broesamle· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ambrine SahalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epigenetic control of S100A8/A9-driven monocytic inflammation licenses anti-leukemic functionality of immature NK cells during hematopoietic stem cell differentiation.

Ronja Larissa Schirrmann, Daniel Stowitschek, Malika Franziska Sutter, J-H Lee, Boyu Zhao, S Lee, Aylin Neyazi, Ben Felix Broesamle, Franziska Ginsberg, Pia Krammer, Ayline Kübler, Thomas Vogl, Helmut Wittkowski, Sarah Ahmad, B Krämer, , Maya Caroline Andre

This study shows that epigenetic priming of healthy donor CD34+ stem cells drives S100A8/A9-driven inflammation, enhancing NK cell anti-leukemic activity during hematopoietic differentiation and improving response to 5-AzaC therapy in MDS.

bioRxiv · Mar 27, 2026 · PreprintImmunology

A platform of robust patient-derived leukemia models covering subgroups for which no cell lines exist

Binje Vick, Vindi Jurinović, Kristina Kuhbandner, Lena Lagally, Lisa Latzko, Chiara Arnreich, Gerulf Hänel, Amelie Muth, Maja Rothenberg‐Thurley, Annika Maria Dufour, Stephanie E. Schneider, Lesca Miriam Holdt, Liliana Mura, Fabian Klein, Annette Frank, , Irmela Jeremias

The paper develops patient-derived AML PDX models that replicate primary AML biology and include subgroups lacking existing models, showing reduced leukemia growth after long-term chemotherapy.

bioRxiv · Sep 26, 2025 · PreprintCancer Biology